Results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19 that were published in the New England Journal of Medicine determined that hydroxychloroquine was not able to prevent the development of COVID-19 any better than a placebo.
Other News
With students, many staff, faculty, and researchers already on campus, and others making plans to return this fall, I want to acknowledge…
A study conducted by the UMN College of Veterinary Medicine found that household cats were more susceptible than dogs to natural infection…
As the first trial of its kind, researchers will use common and widely available drugs to treat symptoms of COVID-19. This story was…